In 2010 Berchier et al reviewed the efficacy of two different concentrations of chlorhexidine mouthrinse ( 0.2 & 0.12% ). A critical appraisal of this review is now available on the American Dental Associations Evidence-based Dentistry website. The commentator notes that a comprehensive search strategy was used although restricted to the English language. Eight studies [read the full story…]
The antiseptic agent Chlorhexidine (CHX) has been widely use to control plaque and gingivitis. The aim of this review was to evaluate, the efficacy of a CHX mouthrinse against plaque growth, gingival inflammation and stain formation in gingivitis patients. What did they do The Medline-PubMed, Embase and the Cochrane Central Register of Controlled Trials databases [read the full story…]
Good oral hygiene is important for the prevention and treatment of periodontal disease. The aim of the study was to assess whether a motivational interview addressing the five dimensions of Leventhal’s theory performed better than conventional basic instruction on improving compliance with plaque control among patients with periodontitis. Patients were randomised to receive either a [read the full story…]
Ventilator-associated pneumonia (VAP) is a life-threatening condition in critically ill patients receiving mechanical ventilation. The incidence of VAP in varies between 9% and 45% with mortality rates of up to 50% . It is accompanied by an increase both in length of stay in intensive care units ICU and healthcare. The aim of this trial [read the full story…]
